Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

53.01 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Soleno Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

INVESTOR NOTICE: Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit filed by Robbins Geller Rudman & Dowd LLP

March 09, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Investor Notice: Robbins LLP Informs Investors of the Soleno Therapeutics, Inc. Class Action Lawsuit

March 06, 2026

From Robbins LLP

Via Business Wire

Aardvark Therapeutics Becomes Next Pharma Player To Quit Prader-Willi Syndrome Drug Development Efforts ↗

February 27, 2026

The company said that the decision was based on certain cardiac observations made during routine safety monitoring in a healthy volunteer study.

Via Stocktwits

Soleno Therapeutics (NASDAQ:SLNO) Beats Q4 2025 Estimates Amid Cautious Market Reaction to VYKAT XR Launch ↗

February 25, 2026

Via Chartmill

Soleno (SLNO) Q4 2025 Earnings Call Transcript ↗

February 25, 2026

Soleno (SLNO) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud Investigation

January 16, 2026

From Kirby McInerney LLP

Via GlobeNewswire

SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.

January 12, 2026

From Kirby McInerney LLP

Via Business Wire

SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP

January 09, 2026

From Kirby McInerney LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

January 08, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO)

December 30, 2025

From Kirby McInerney LLP

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

Rhythm Pharmaceuticals Faces Gravity: FDA Delays and Valuation Pressures Cool 2025’s Biotech Darling

December 30, 2025

As the final trading days of 2025 wind down, Rhythm Pharmaceuticals (Nasdaq: RYTM) finds itself at a critical crossroads. After a meteoric rise that saw the stock gain over 100% through the first three...

Via MarketMinute

Topics ETFs Economy World Trade

Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗

December 03, 2025

Soleno just turned profitable for the first time—right as a major fund made its move.

Via The Motley Fool

Topics Regulatory Compliance

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

December 03, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

November 18, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Soleno Therapeutics Unveils $100 Million Buyback Citing 'Underappreciated' Future ↗

November 11, 2025

Soleno Therapeutics (SLNO) approved $100M share repurchase program & entered ASR agreement with Jefferies LLC to buy back its stock.

Via Benzinga

PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday ↗

November 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 11, 2025

Via Benzinga

SLNO INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Soleno Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm

November 11, 2025

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm

November 10, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

These stocks are moving in today's session ↗

November 05, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 05, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

November 05, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

November 05, 2025

Via Benzinga

What's going on in today's after hours session ↗

November 04, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 04, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.